Geneva Bioinformatics (Genebio) SA – Trademark Portfolio
Entity Type: 99
Geneva Bioinformatics (Genebio) SA holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 7 Nice Classification classes.
Avenue de Champel 25
CH-1200 Genève
Showing of trademarks Trademarks
Trademark Classifications
Geneva Bioinformatics (Genebio) SA's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Geneva Bioinformatics (Genebio) SA have?
Geneva Bioinformatics (Genebio) SA has 8 U.S. trademarks filed with the USPTO.
What trademark classes does Geneva Bioinformatics (Genebio) SA file in?
Geneva Bioinformatics (Genebio) SA files trademarks across 7 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 16 (Paper Goods), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What is Geneva Bioinformatics (Genebio) SA's trademark registration success rate?
Geneva Bioinformatics (Genebio) SA has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.